Welcome to Lonza Bioscience

The follow article will summarize the therapeutic properties of MSCs, quality attributes, expansion methods, as well as some major challenges these cells create when used in cell therapy applications. 

Learn more about our integrated solutions which can support you from drug discovery to development for SARS-CoV-2. Choose from a broad donor panel of airway and immune cells, culture media for primary cells, media and endotoxin testing products for vaccine and protein production, or use our Nucleofector^TM Technology for virus creation.  

Gain ease of mind by adopting the new GSv9^TM Media and Feeds for protein production, offering high titer and protein quality with low aggregate formation.

The new TheraPEAK^TM SfAAV^TM Medium enhances your AAV production in Sf9 cells and expedites the time to market for safe, scalable and live-saving gene therapies.

High-quality media solutions are vital for recombinant protein manufacture. Discover how Lonza’s new eCHO^TM Medium can support a consistent yield of high-quality products, while being easy and economical to use.

As the situation with the COVID-19 pandemic evolves, we will keep you informed about any potential supply disruptions which may occur as a result.

QC Insider^TM Toolbox is packed with comprehensive support tools that will help you perform the bacterial endotoxins test. It has been created by QC experts who face many of the same regulated manufacturing challenges as you do.

Keep up to speed on the latest scientific developments, events, tips and tools from Lonza.

Our Modular Automated Sampling Technology (MAST) provides automated aseptic sampling from up to 10 sterile sample sources, like your bioreactor, and sends those samples for multiple automated analyses or collection processes. Improve your process understanding and maximize efficiencies with MAST.